BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 23519096)

  • 1. Impact of time-to-treatment on myocardial perfusion after primary percutaneous coronary intervention with Gp IIb-IIIa inhibitors.
    De Luca G; Gibson MC; Hof AW; Cutlip D; Zeymer U; Noc M; Maioli M; Zorman S; Gabriel MH; Secco GG; Emre A; Dudek D; Rakowski T; Gyongyosi M; Huber K; Bellandi F;
    J Cardiovasc Med (Hagerstown); 2013 Nov; 14(11):815-20. PubMed ID: 23519096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors.
    De Luca G; Gibson M; Cutlip D; Huber K; Dudek D; Bellandi F; Noc M; Maioli M; Zorman S; Zeymer U; Secco GG; Mesquita Gabriel H; Emre A; Arntz HR; Rakowski T; Gyongyosi M; Hof AW;
    Arch Cardiovasc Dis; 2013 Mar; 106(3):155-61. PubMed ID: 23582677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation.
    De Luca G; Gibson CM; Huber K; Dudek D; Cutlip D; Zeymer U; Gyöngyösi M; Bellandi F; Noc M; Arntz HR; Maioli M; Secco GG; Zorman S; Gabriel HM; Emre A; Rakowski T; Van't Hof AW;
    EuroIntervention; 2012 Aug; 8(4):470-6. PubMed ID: 22917731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of preprocedural TIMI flow on myocardial perfusion, distal embolization and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb/IIIa inhibitors.
    Maioli M; Zeymer U; van 't Hof AW; Gibson CM; Dudek D; Bellandi F; Noc M; Secco GG; Zorman S; Gabriel HM; Emre A; Cutlip D; Rakowski T; Gyongyosi M; Huber K; De Luca G;
    J Invasive Cardiol; 2012 Jul; 24(7):324-7. PubMed ID: 22781470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors.
    De Luca G; Gibson CM; Bellandi F; Noc M; Dudek D; Zeymer U; Arntz HR; Cutlip D; Maioli M; Zorman S; Mesquita Gabriel H; Emre A; Rakowski T; Gyongyosi M; Huber K; Van't Hof AW
    Atherosclerosis; 2009 Nov; 207(1):181-5. PubMed ID: 19426981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT cooperation).
    De Luca G; Van't Hof AW; Gibson CM; Cutlip D; Zeymer U; Noc M; Maioli M; Zorman S; Gabriel HM; Emre A; Rakowski T; Gyongyosi M; Huber K; Bellandi F; Dudek D;
    Am J Cardiol; 2015 Mar; 115(6):711-5. PubMed ID: 25655867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors.
    De Luca G; van't Hof AW; Huber K; Gibson CM; Bellandi F; Arntz HR; Maioli M; Noc M; Zorman S; Secco GG; Zeymer U; Gabriel HM; Emre A; Cutlip D; Rakowski T; Gyongyosi M; Dudek D
    Heart Vessels; 2014 Jan; 29(1):15-20. PubMed ID: 23494604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with ST segment elevation myocardial infarction undergoing primary angioplasty.
    De Luca G; van't Hof AW; Huber K; Gibson CM; Bellandi F; Arntz HR; Maioli M; Noc M; Zorman S; Zeymer U; Gabriel HM; Emre A; Cutlip D; Rakowski T; Gyongyosi M; Dudek D;
    Am J Cardiol; 2013 Oct; 112(8):1083-6. PubMed ID: 23910428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of distal embolization on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation.
    De Luca G; Gibson CM; Bellandi F; Noc M; Maioli M; Zorman S; Zeymer U; Gabriel HM; Emre A; Cutlip D; Arntz HR; Dudek D; Rakowski T; Gyongyosi M; Huber K; van't Hof AW
    J Thromb Thrombolysis; 2010 Jul; 30(1):23-8. PubMed ID: 19921103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitated angioplasty with combo therapy among patients with ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
    De Luca G; Marino P
    Am J Emerg Med; 2009 Jul; 27(6):683-90. PubMed ID: 19751625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between advanced Killip class at presentation and impaired myocardial perfusion among patients with ST-segment elevation myocardial infarction treated with primary angioplasty and adjunctive glycoprotein IIb-IIIa inhibitors.
    De Luca G; Gibson CM; Huber K; Zeymer U; Dudek D; Cutlip D; Bellandi F; Noc M; Emre A; Zorman S; Gabriel HM; Maioli M; Rakowski T; Gyöngyösi M; Van't Hof AW;
    Am Heart J; 2009 Sep; 158(3):416-21. PubMed ID: 19699865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study.
    Campo G; Valgimigli M; Gemmati D; Percoco G; Tognazzo S; Cicchitelli G; Catozzi L; Malagutti P; Anselmi M; Vassanelli C; Scapoli G; Ferrari R
    J Am Coll Cardiol; 2006 Dec; 48(11):2178-85. PubMed ID: 17161242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation.
    De Luca G; Gibson CM; Gyöngyösi M; Zeymer U; Dudek D; Arntz HR; Bellandi F; Maioli M; Noc M; Zorman S; Gabriel HM; Emre A; Cutlip D; Rakowski T; Huber K; van't Hof AW
    J Thromb Thrombolysis; 2010 Oct; 30(3):342-6. PubMed ID: 20213259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis.
    Montalescot G; Borentain M; Payot L; Collet JP; Thomas D
    JAMA; 2004 Jul; 292(3):362-6. PubMed ID: 15265852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis.
    De Luca G; Gibson CM; Bellandi F; Murphy S; Maioli M; Noc M; Zeymer U; Dudek D; Arntz HR; Zorman S; Gabriel HM; Emre A; Cutlip D; Biondi-Zoccai G; Rakowski T; Gyongyosi M; Marino P; Huber K; van't Hof AW
    Heart; 2008 Dec; 94(12):1548-58. PubMed ID: 18474534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of electrocardiographic and angiographic markers of reperfusion in the prediction of infarct size in patients with ST-segment elevation myocardial infarction undergoing successful primary angioplasty.
    De Luca G; Suryapranata H; de Boer MJ; Ottervanger JP; Hoorntje JC; Gosselink AT; Dambrink JH; Ernst N; van 't Hof AW;
    Int J Cardiol; 2007 Apr; 117(2):232-7. PubMed ID: 16899313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of multivessel disease on infarct size among STEMI patients undergoing primary angioplasty.
    De Luca G; Parodi G; Sciagrà R; Bellandi B; Comito V; Vergara R; Migliorini A; Valenti R; Antoniucci D
    Atherosclerosis; 2014 May; 234(1):244-8. PubMed ID: 24685816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tirofiban therapy on ST segment resolution and clinical outcomes in patients with ST segment elevated acute myocardial infarction undergoing primary angioplasty.
    Uyarel H; Uzunlar B; Unal Dayi S; Tartan Z; Samur H; Kasikcioglu H; Akgul O; Simsek D; Erdem I; Okmen E; Cam N
    Cardiology; 2006; 105(3):168-75. PubMed ID: 16479104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.